Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1/2 1

Status

Completed 3Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Breast 23Genitourinary 20Other 15Gastrointestinal 13Lymphoid 11Plasma cell 8Gynecologic 5Thoracic 4Head & Neck 4Endocrine 4Other hematologic neoplasm 2Sarcoma 1Classical hematology 1

Conditions

Neuroendocrine Tumors 394Multiple Endocrine Neoplasia Type 1 156Carcinoma, Neuroendocrine 123Thyroid Cancer, Papillary 118Pituitary Neoplasms 114Thyroid Neoplasms 100Pheochromocytoma 91Neoplasms 79Carcinoid Tumor 76Thyroid Carcinoma, Anaplastic 73Adrenocortical Carcinoma 73Paraganglioma 65Neoplasm Metastasis 56Adenocarcinoma, Follicular 53Carcinoma, Non-Small-Cell Lung 51Carcinoma, Medullary 50Insulinoma 49Pancreatic Neoplasms 47Adenoma, Islet Cell 47Colorectal Neoplasms 44Breast Neoplasms 44Small Cell Lung Carcinoma 42Sarcoma 42Gastro-enteropancreatic neuroendocrine tumor 42Carcinoma, Renal Cell 41Somatostatinoma 38Head and Neck Neoplasms 38Melanoma 37Lung Neoplasms 37Adrenal Gland Neoplasms 34

Interventions

Diet, Mediterranean 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Cardiovascular Diseases × Endocrine × Clear all
NCT04530916 2025-11-17

WB2020

Colorado State University

Phase 1/2 Active not recruiting
58 enrolled
Endocrine

Cardiovascular Diseases, Hypertension, Multiple Endocrine Neoplasia Type 1, Atherosclerosis

NCT04267263 2021-07-26

A Novel Approach to Reducing Adiposity Among Young Men

Virginia Commonwealth University

Phase NA Completed
35 enrolled
EndocrineOther

Cardiovascular Diseases, Obesity, Weight Loss, Multiple Endocrine Neoplasia Type 1, Risk Reduction Behavior

NCT01852721 2013-09-06

Effects of the Mediterranean Diet on Cardiovascular Risk Profile in Men and Women (ALIMED)-Part 2

Laval University

Phase NA Completed
123 enrolled
Endocrine

Cardiovascular Diseases, Feeding Behavior, Multiple Endocrine Neoplasia Type 1

NCT01293344 2011-10-07

ALIMED

Laval University

Phase NA Completed
70 enrolled
Endocrine

Cardiovascular Diseases, Insulin Resistance, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡